SCHEMBL8947223

SCHEMBL8947223

COC(=O)CNC(=O)c1cccc(F)c1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.60
GPR139 Q6DWJ6 1/20 0.56
NPC1 O15118 3/20 0.56
RAB9A P51151 3/20 0.56
HDAC1 Q13547 1/20 0.56
HDAC6 Q9UBN7 1/20 0.56
KDM4E B2RXH2 4/20 0.55
ALDH1A1 P00352 2/20 0.55
GAA P10253 2/20 0.54
MAPT P10636 1/20 0.54
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
LMNA P02545 2/20 0.54
HPGD P15428 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.51
PKM P14618 1/20 0.51
HTT P42858 1/20 0.50
TSHR P16473 1/20 0.49
HSD17B10 Q99714 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26579684 0.84 MAPK1 (0.76) MAPK1NPC1RAB9AKDM4EALDH1A1
SCHEMBL30739865 0.84 GPR139 (0.59) GPR139NPC1RAB9AHDAC1HDAC6
SCHEMBL13144463 0.83 MAPK1 (0.62) MAPK1GPR139NPC1RAB9AHDAC6
SCHEMBL2204173 0.83 NPC1 (0.57) GPR139NPC1RAB9AHDAC1HDAC6
SCHEMBL31148337 0.82 HDAC1 (0.61) GPR139NPC1RAB9AHDAC1HDAC6
SCHEMBL8947129 0.82 POLB (0.68) MAPK1GPR139HDAC1ALDH1A1LMNA
SCHEMBL6160025 0.81 MAPK1 (0.60) MAPK1KDM4EALDH1A1GAAMEN1
SCHEMBL8947214 0.81 MAPK1 (0.72) MAPK1GPR139NPC1RAB9AKDM4E
SCHEMBL31178805 0.81 MAPK1 (0.72) MAPK1GPR139NPC1RAB9AKDM4E
SCHEMBL10064202 0.81 MEN1 (0.65) MAPK1GPR139NPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE35281-E ANTIDIABETIC AGENTS WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 1996-06-18 US disclosed
EP-0388967-B1 Aldose reductase inhibitor WAKAMOTO PHARMA CO LTD (JP) 1995-06-28 EP disclosed
US-5055481-A Alleviate diabetic complications WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 1991-10-08 US disclosed
EP-0388967-A1 Aldose reductase inhibitor Wakamoto Pharmaceutical Co., Ltd. (JP) 1990-09-26 EP disclosed